Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study
Crossref DOI link: https://doi.org/10.1038/s41598-021-03055-8
Published Online: 2021-12-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Won Young
Kim, Hee Ju
Kim, Eun Young
Text and Data Mining valid from 2021-12-16
Version of Record valid from 2021-12-16
Article History
Received: 4 July 2021
Accepted: 24 November 2021
First Online: 16 December 2021
Competing interests
: The authors declare no competing interests.